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INTRODUCTION 
Nosocomial bloodstream infections are important 
infections with a high attributable mortality. Pre- 
vention of nosocomial bloodstream infections should 
be aimed at the primary source of the infection. 
When bloodstream infections are secondary to a 
source of infection elsewhere in the body, prevention 
should be aimed at this source. This paper deals with 
the prevention of primary bloodstream infections 
which is equivalent to intravascular catheter-related 
bloodstream infections. 
Reliable access to the vascular system has become 
one of the most essential features of modern medical 
care. Therefore, approximately 150 million intra- 
vascular devices are used annually in the United States. 
Apart from the benefits of these devices there are 
several undesirable side-effects. Intravascular devices 
are the major cause of nosocomial bloodstream 
infections, which are associated with a 14-28% 
attributable mortality [ 1-31, Although the vast 
majority of intravascular catheters used are peripheral 
lines, bloodstream infections are mainly caused by 
central lines. These infections are largely preventable 
by adhering to simple and practical guidelines. This 
paper summarizes those measures which are of proven 
value in preventing intravascular catheter-related blood- 
stream infections, and gives some considerations for 
future developments. 
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PATHOGENESIS 
There are four major sites where intravascular catheter- 
related bloodstream infections can arise. First, the 
insertion site is a major port of entrance. Pathogens can 
quickly migrate from the skin at the insertion site to 
the catheter tip along the outer surface of the catheter 
[4,5]. At the catheter tip microorganisms are incorpor- 
ated in a bio-film consisting of a thick matrix of 
glycocalix. This so-called slime layer provides an ideal 
micro-climate for bacteria and fungi to adhere and 
grow out. The slime layer protects the microorganisms 
from the host defense mechanisms and from the activity 
of antibiotics. The second port of entry is colonization 
of the hub. Catheter hubs are a common cause of 
intravascular catheter-related bloodstream infections 
[6,7]. These two portals of entry are the most frequent 
causes of intravascular catheter-related bloodstream 
infections. The relative importance of the insertion site 
versus the hub may vary in different institutions due to 
differences in local care during insertion, different 
duration of catheterization, different types of catheter 
material and differences in care of the hub. Two other 
possible mechanisms which are far less frequent in 
modern settings are hematogenous seeding from a 
remote focus of infection and contaminated infusate. 
The latter used to be a frequent cause in earlier days 
when manufacturing of parenteral medication was less 
sophisticated. However, currently this problem should 
be under control. 
PREVENTION 
Antibiotic prophylaxis during insertion 
The few studies which dealt with this issue have shown 
conflicting results. This, combined with the risk of 
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widespread resistance associated with such extensive use 
of prophylactic antibiotics, means that this practice is 
not recommended [8]. 
Site of insertion 
The internal jugular vein is associated with a higher 
catheter colonization rate and a higher intravascular 
catheter-related bloodstream infection rate than the 
subclavian vein [9-111. This is probably caused by an 
increased bacterial colonization density at the internal 
jugular insertion site and by a more difficult immobiliz- 
ation of the catheter at this site. O n  the other hand, 
insertion in the subclavian vein is associated with an 
increased risk for non-infectious complications, e.g. 
pneuniothorax. The risks of infection of the femoral 
veins as the insertion site remains controversial 
[9,10,12]. 
Precautions during insertion 
During insertion of peripheral lines, wearing of sterile 
gloves is not recommended. Peripheral lines in general 
have a low risk of infection, certainly when compared 
with central lines. Several studies have examined the 
effect of maximal barrier precautions during insertion 
of central lines. This included the wearing of a mask, 
cap, sterile gown, sterile gloves and a large sterile 
drape. All studies showed a significant reduction in the 
intravascular catheter-related bloodstream infection 
rate [13-151. The importance of the level of care 
during insertion and during follow-up has also been 
shown by several investigators looking at the effect of 
a specialized IV-team. Such teams were highly cost- 
effective in several studies [16]. Furthermore, it has 
been shown that adequate staffing of nurses for patients 
with IVD is important to prevent intravascular 
catheter-related bloodstream infections. Some specific 
aspects of catheter care during insertion will be 
discussed below. 
Skin antisepsis 
The iniportance of the agent used for skin antisepsis 
and for subsequent care of the insertion site was 
demonstrated in a large study by Maki et al. [17]. They 
found that 2% aqueous chlorhexidine was associated 
with a significant lower intravascular catheter-related 
bloodstream infection rate than povidone-iodine 10% 
or alcohol 70%. Other studies evaluated the effect of 
adding alcohol to either iodine or chlorhexidine. Both 
combinations were superior to povidone-iodine [ 181. 
Although clinical studies showing a different in vivo 
effect of one of the two combinations are lacking, the 
combination of alcohol and chlorhexidine is preferred 
because of the superior activity of chlorhexidine com- 
pared to povidone-iodine. 
Topical antimicrobial ointments 
Although this seems an attractive strategy from a 
theoretical point of view, there have been few well 
designed studies performed to date. Polyantibiotic 
ointments were associated with a moderate effect on 
bacterial colonization rates. Moreover, they were 
associated with increased candida infection rates. 
Mupirocin ointment was associated with a lower 
catheter colonization rate in several studies. No 
significant effect on the intravavxlar catheter-related 
bloodstream infection rate has been demonstrated. 
Moreover, colonization as an outcome is a difficult 
item with antimicrobial ointments because they 
interfere with the reliability of culture results from the 
catheter tip. In view of these findings and the potential 
risk of resistance with this application of antibiotics it 
is currently not recommended 1161. The most 
interesting studies in this field were done with skin 
antiseptics, i.e. povidone-iodine ointment. One study 
found no effect while the other found a fourfold 
reduction [16]. This strategy aimed at the insertion site 
is attractive and warrants more extensive investigations. 
Dressings 
The use of sterile gauze for dressing of the catheter 
insertion site is more and more replaced by transparent 
polyurethane dressings. The advantages of transparent 
dressings are that they permit continuous inspection of 
the insertion site, they secure the device reliably and 
are more conifortable to the patient. On the other 
hand, they are more expensive 2nd it is uncertain what 
the effect of occlusion of the skin surrounding the 
insertion site is on the cutaneous microflora. O n  
peripheral catheters a number of studies have been 
performed. There is some controversy as to whether 
transparent dressings increase the catheter colonization 
rate, but the rate of intravascular catheter-related 
bloodstream infections associated with peripheral lines 
is so low that both sterile gauze and transparent 
dressings can be used safely. The more important 
group are the central vascular catheters. In this group 
the controversy builds up. Many studies have been 
performed, resulting in as many different outconies. 
The problems are manifold. First, there are several 
kinds of different dressings and there are several kind 
of protocols dealing with those dressings. The 
variations include the method of skin disinfection and 
the dressing replacement Interval. Considering these 
variations it is difficult to draw final conclusions. For 
central venous lines it is currently considered to be safe 
to use transparent polyurethane dressings for pro- 
longed periods. Two recent studies suggest that for 
arterial catheters transparent dressings may be less safe 
than sterile gauze and tape [16]. 
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Routine changing of catheters 
The risk of infection increases linearly over time. 
Therefore, the risk for each successive day is no greater 
than for any previous day. Routine changing of 
intravascular catheters at certain intervals is therefore 
not recommended. An exception to this rule may be 
Swan-Ganz pulmonary artery catheters. The infectious 
risk of these catheters rises after the fifth day of 
catheterization and it may therefore not be safe to leave 
these catheters in place for more than five days. 
Changing over a guidewire 
Changing a catheter over a guidewire is attractive since 
it eliminates many non-infectious risks associated with 
a new puncture site. However, if the site of catheter- 
ization is infected there is an increased risk of infection 
associated with changing over the guidewire. In practice 
the following strategy is an attractive compromise [16]. 
When an intravascular catheter is in place for a 
prolonged period and there is suspicion of infection it 
is acceptable to change the catheter over a guidewire in 
the same site. It is mandatory to culture the tip of the 
catheter which is removed and to take blood cultures. 
When these cultures show that the catheter was 
significantly colonized, the new catheter should be 
removed immediately to prevent the development of a 
bloodstream infection. In this case a new insertion site 
is mandatory. When there are local signs of infection at 
the insertion site or when the patient has symptoms of 
sepsis it is not recommended to use the guidewire 
technique but to choose another insertion site initially. 
Routine changing of the infusion set 
The period for which the infusion system can be in 
place safely is currently a matter of investigation. For 
decades the interval considered to be safe has been 
24-48 hours. Recent studies showed that 72 hours gave 
comparable results [19-211, and longer intervals are 
under investigation. Nowadays, 72 hours is considered 
to be safe in general. As an exception to this rule, 
24-hour intervals are still recommended when blood or 
blood products have been administered and for lipid 
emulsions. Longer intervals may further reduce the 
costs associated with intravascular therapy, but by 
increasing the interval the chance for significant out- 
growth of contaminating micro-organisms increases, 
thereby increasing the risk for intravascular catheter- 
related bloodstream infections. The risks for additional 
prolonging of the interval should be studied carefully 
before being widely implemented. 
In-line filters 
In-line filters can have a beneficial effect if the infusate 
is contaminated. As stated above this kind of contamin- 
ation is nowadays rare. In addition, these filters should 
be changed regularly and can become blocked, thereby 
increasing the number of manipulations of the system 
and thus enhancing the risk of contamination. More- 
over, filters increase the cost of infusion therapy. There- 
fore, in-line filters are not recommended for routine 
use. 
The hub 
The importance of the hub as a source of intravascular 
catheter-related bloodstream infection is often under- 
estimated. Many hospitals still do not have a written 
policy for care of the hub [22]. The longer a catheter 
remains in place, the greater the importance of the hub 
as a source of contamination [23]. It is important to 
disinfect the hub when manipulating it. New hubs are 
being designed aimed at reducing contamination. One 
hub with an iodine tincture reservoir at the connection 
site resulted in a major reduction in the intravascular 
catheter-related bloodstream infection rate [23]. This 
study was performed in a setting with a remarkably high 
intravascular catheter-related bloodstream infection 
rate. The value of this hub in low incidence settings 
should be investigated. Another development is needle- 
less connecting systems. Initially these systems were 
developed to reduce the chance of needlestick accidents. 
There are currently no studies available on the risk of 
contamination and infection associated with these 
systems. Several anecdotal reports have documented a 
higher intravascular catheter-related bloodstream 
infection rate after the introduction of needle-less 
systems [24,25]. These increased rates may have been 
caused by inappropriate handling of the needle-less 
connection system. Because of these uncertainties the 
use of needle-less systems is not recommended until 
well designed trials have proved their safety in clinical 
practice. 
New catheters and cuffs 
A silver-impregnated tissue interface barrier has been 
developed, to prevent migration of microorganisms 
from the skin surrounding the insertion site along the 
catheter surface to the tip. It consists of a detachable, 
biodegradable collagen cuff with silver ion (Vitacuff, 
Vitafore Corporation, San Carlos, California, USA). 
The cuff can be attached to a central vascular catheter 
and is placed just below the skin. Subcutaneous tissue 
rapidly grows into the collagen matrix, creating a 
mechanical barrier against migrating microorganisms. 
This mechanical barrier is enforced by a chemical 
(silver ion) barrier. Several studies found a short- 
term reduction of the intravascular catheter-related 
bloodstream infection rate using this device [26,27]. 
However, when the duration of catheterization was 
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more than two weeks no protective effect of the cuff 
was found [28,29]. This is probably due to the 
increasing importance of endoluminal contamination 
when the duration of catheterization increases [23]. 
The extraluininal cuff cannot protect against the 
endoluminal (i.e. the hub) route. More recent 
developments have been aimed at the prevention of 
adherence to the catheter material by using various 
materials. Both antiseptics and antibiotics have been 
incorporated in the catheter surface. Catheters coated 
with a combination of minocyclin and rifampin 
resulted in a decreased catheter colonization rate and a 
decreased catheter-related BSI rate [30]. However, the 
widespread use of these catheters is not recommended 
because of the risk of development of resistance to these 
valuable antibiotics. A catheter impregnated with silver 
sulfadiazine and chlorhexidine (Arrowgard; Arrow 
International, Reading, Pennsylvania, USA) also showed 
a significant reduction of catheter-related bacteremia in 
two studies. Further studies showed that with pro- 
longed duration of catheterization the effect dis- 
appeared [16]. Further promising developments are to 
be expected from using new catheter materials which 
are less prone to adherence by microorganisms or by 
modifying existing materials. 
CONCLUSIONS 
Certainly, advances have been made over the past 
decades which have made intravascular therapy and 
intravascular support safer for the patients. The infusate 
used to be a serious problem, which has largely been 
solved. Despite these efforts catheter-related bacteremia 
remains a relatively frequent and serious problem which 
deserves our ongoing attention. Many measures have 
been studied to further reduce the intravascular 
catheter-related bloodstream infection rate. Some 
measures have proven their value repeatedly, some have 
been shown to be of little or no effect at all. Unfortun- 
ately, most measures have shown conflicting results and 
their value is still uncertain. This causes undesirable 
differences in local protocols. In Table 1 the measures 
which have proven their value are summarized. The 
classification ‘proven’ does not mean that there is no 
doubt left about the value of the specific item. O n  each 
specific measure there are only a few studies performed. 
In these studies the effect was statistically significant, 
which does not guarantee the same effect in other 
settings. Therefore, it should be realized that these 
recommendations may change in the future. These 
proposed ‘changes’ would implicitly mean that more 
well designed studies have been performed in the field 
of intravascular catheter-related bloodstream infection, 
studies which should be encouraged, considering the 
Table 1 Measures for the prevention of intravascular 
catheter-related bloodstream infections 
Measure 
0 
insertion in the subclavian vein has the lowest infection rate* 
maximal barrier precautions should be taken during insertion 
aseptic handling of the insertion site and of the hub is 
niandatory 
IV teams are associated with significant reduction of the 
infection rate 
for skin antisepsis a mixture of povidone iodine with alcohol or 
chlorhexidine with alcohol is preferable 
routine changing of central vascular catheters is not effective, 
except for Swan-Ganz pulnionary artery catheters (interval five 
days) 
routine changing of the intravenous tubing set is safe at 72 hour 
intervals, except when blood or blood products and lipid 
emulsions have been used, then the interval is 24 hour? 
a tissue-interface barrier (Vitacuq has a short-term effect 
impregnation of the catheter with silver sulfadiazine and 
chlorhexidme has a short-term effect 
coating of the catheter with antibiotics is effective but is not 
recommended due to the danger of development of resistaiicc 
new hub design aimed at reduced contamination was effective 
in  a high incidence setting and should be investigated in low 
incidence settings 
the safety of needleless connecting devices has not been 
demonstrated yet 
*Other non-infectious complications should be considered as well. 
importance of this iatrogenic and largely preventable 
disease. 
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